Denemek ALTIN - Özgür
Contingency plans in play for apparel, drug, tyre cos
Mint Ahmedabad
|June 04, 2025
Firms tweak business strategies to mitigate risk emanating from 10% US tariffs on all imports
Indian exporters of apparel, automotive parts, pharmaceuticals and tyres—with significant shipments to the US—are preparing contingency plans or revising their business strategies to mitigate the business risk from the imposition of tariffs.
US President Donald Trump's administration has imposed a 10% universal tariff on all imports from every country, including India.
Gokaldas Exports Ltd, a listed garments exporter, will focus on expanding its business in Europe because tariffs have hurt business with its main export market—the US.
"Since there is a lot of tariff uncertainty, we are pivoting to Europe. The idea is not to reduce our US business in absolute terms, but for incremental business we will focus on Europe including the UK," said Sivaramakrishnan Ganapathi, managing director of Gokaldas Exports.
Margins of apparel exporters including Gokaldas have come under pressure following the tariff levy. US retailers have been unable to pass on the increased cost to consumers and are pushing for their suppliers to share the burden, Ganapathi said.
"In the short term, we may also have to bear some of that cost just to keep up the relationships," he said.
Gokaldas got about three-fourths of its ₹3,864 crore FY25 revenue from the US.
Bu hikaye Mint Ahmedabad dergisinin June 04, 2025 baskısından alınmıştır.
Binlerce özenle seçilmiş premium hikayeye ve 9.000'den fazla dergi ve gazeteye erişmek için Magzter GOLD'a abone olun.
Zaten abone misiniz? Oturum aç
Mint Ahmedabad'den DAHA FAZLA HİKAYE
Mint Ahmedabad
Pet care startups eye users to compete with FMCG giants
Direct-to-consumer (D2C) pet care brands are leaning on subscription models to lock in customers, betting that repeat purchases can help them counter the scale and distribution advantage of India's largest packaged consumer goods players as the niche segment heats up.
2 mins
January 23, 2026
Mint Ahmedabad
Zydus launches cancer biosimilar
Zydus Lifesciences has launched its biosimilar of anticancer drug nivolumab in India after receiving clearance from the Delhi High Court last week, pricing it at a fraction of the patented version.
1 min
January 23, 2026
Mint Ahmedabad
Retail boosts IPO odds via parent shares
A smart move? Investors are reviving an old strategy by buying parent shares ahead of subsidiary IPOs.
3 mins
January 23, 2026
Mint Ahmedabad
WHY INDIA NEEDS TO RETHINK ITS WAR CHEST
FDI drain is emerging as a silent threat to India's foreign exchange reserves. How can the leak be plugged?
6 mins
January 23, 2026
Mint Ahmedabad
India needs long-term solutions to address its inequality problem
Cash transfers are expedient but we must intervene strongly in the labour market to fix distortions
3 mins
January 23, 2026
Mint Ahmedabad
IndiGo cuts growth outlook as Q3 profit sinks to 4-yr low
Net profit slipped to 549 crore in Q3, hit by a one-time exceptional cost of 1,546.5 crore
3 mins
January 23, 2026
Mint Ahmedabad
Banks renew push to unsecured loans
India's banks are cautiously reopening the tap on unsecured lending, as policy rate cuts drive margin pressure and risks stay largely under control.
1 min
January 23, 2026
Mint Ahmedabad
Blinkit’s Q3 profit a shift or blip?
Eternal Ltd’s Q3FY26 results were encouraging on many counts.
2 mins
January 23, 2026
Mint Ahmedabad
An India-France tale on cloth
A recent Paris show celebrated 400 years of textile history between the two nations, showcasing shared crafts
4 mins
January 23, 2026
Mint Ahmedabad
Small finance banks hunt for peer talent to grow
SFBs are eyeing senior executives at larger banks in universal banking bid
2 mins
January 23, 2026
Listen
Translate
Change font size

